US 10781242
Interleukin-2 fusion proteins and uses thereof
granted A61KA61K38/00A61K38/1761
Quick answer
US patent 10781242 (Interleukin-2 fusion proteins and uses thereof) held by Medicenna Therapeutics Inc. expires Mon Sep 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Medicenna Therapeutics Inc.
- Grant date
- Tue Sep 22 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K38/00, A61K38/1761, A61K38/2013, A61P